News

Filter

Current filters:

Pricing

176 to 185 of 96906 results

Actavis third-qtr sales rocket, but loss posted

Actavis third-qtr sales rocket, but loss posted

05-11-2014

Ireland-headquartered generics drug major Actavis today reported net revenue leapt 83% to $3.7 billion…

ActavisFinancialGenerics

Vertex seeks regulatory approval for lumacaftor/ivacaftor combination for CF

05-11-2014

US biotech firm Vertex Pharmaceuticals has filed for marketing approval for a fully co-formulated combination…

BiotechnologyEuropeivacaftorlumacaftorRare diseasesRegulationUSAVertex Pharmaceuticals

FDA responds to Public Citizen antacid petition from 2011

FDA responds to Public Citizen antacid petition from 2011

05-11-2014

The US Food and Drug Administration has responded to a 2011 petition from consumer rights advocacy group…

Gastro-intestinalsNexiumPharmaceuticalPrevacidPrilosecRegulationUSA

Isis Pharmaceuticals receives first $7.5 million milestone payment from AstraZeneca for ISIS-STAT3

Isis Pharmaceuticals receives first $7.5 million milestone payment from AstraZeneca for ISIS-STAT3

05-11-2014

US pharma company Isis Pharmaceuticals has earned the first of two milestone payments from Anglo-Swedish…

AstraZenecaIsis PharmaceuticalsISIS-STAT3RxOncologyPharmaceuticalResearchUSA

New products do well, but sales and profit down at Lundbeck

New products do well, but sales and profit down at Lundbeck

05-11-2014

In what was clearly a difficult period for Danish CNS specialist Lundbeck due to patient expiries, the…

EuropeFinancialLundbeckNeurologicalPharmaceutical

Teva expands laquinimod program with Active Biotech

05-11-2014

Israeli generics giant Teva Pharmaceutical Industries and Sweden’s Active Biotech are expanding their…

Active BiotechlaquinimodNerventraNeurologicalPharmaceuticalResearchTeva Pharmaceutcal Industries

Israel’s pharma market will grow to over $2.3 billion by 2020, report

05-11-2014

Israel’s pharmaceutical market value will increase from around $1.9 billion in 2013 to $2.34 billion…

IsraelMarkets & MarketingPharmaceuticalResearchTeva Pharmaceutcal Industries

CNS drugs development takes longer than other drugs, says Tufts CSDD

05-11-2014

Drugs that treat central nervous system (CNS) diseases take more than a year longer to develop and are…

NeurologicalPharmaceuticalRegulationResearchUSA

176 to 185 of 96906 results

Back to top